Temporary Equity and Stockholders' Deficiency (Details Narrative)

v3.21.1

Temporary Equity and Stockholders' Deficiency (Details Narrative) - USD ($)																2 Months Ended		3 Months Ended	12 Months Ended
	Oct. 30, 2020	Oct. 29, 2020	Oct. 23, 2020	Oct. 03, 2020	Oct. 01, 2020	Sep. 28, 2020	Sep. 02, 2020	Feb. 18, 2020	Aug. 05, 2019	Jul. 23, 2019	Jul. 08, 2019	May 13, 2019	Mar. 13, 2019	Jan. 31, 2019	Jan. 31, 2019	Dec. 18, 2020	Aug. 30, 2019	Jun. 30, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Sep. 03, 2020	Oct. 05, 2018	Jul. 27, 2018	Feb. 28, 2017
Common stock, shares authorized							80,000,000												150,000,000	150,000,000		150,000,000
Common stock, par or stated value per share																			$ 0.01	$ 0.01
Common stock, shares, issued																			5,234,406	4,021,470
Common stock, shares, outstanding																			5,231,037	4,018,101
Preferred stock, shares authorized																			11,000,000	11,000,000
Number of stock options granted during the period																			115,681
Common stock issued under 401(k) profit sharing plan, value																			$ 52,732	$ 63,414
Number of shares issued for consulting service																			108,266
Accounts payable																			891,168	823,762
Common stock issued for cash, value																				4,610,700
Foreign currency translation adjustments																			$ 467,032	$ 710,386
Number of cancelled warrants purchase shares
Weighted average grant date value																			$ 0.18	$ 0.10
Share-based payment award, fair value assumptions, expected volatility rate																			58.00%
Share-based payment award, fair value assumptions, expected dividend rate																			0.00%	0.00%
Options [Member]
Share based compensation																			$ 361,253	$ 432,187
Unrecognized stock-based compensation expense																			$ 821,049
Unrecognized stock-based compensation expense, amortized weighted average period																			2 years 6 months 21 days
2017 Notes [Member]
Number of shares issued conversion of debt																		5,573
Satisfaction of Debt Obligations [Member]
Number of shares issued conversion of debt																	9,659
New Convertible Notes [Member]
Shares converted into stock							247,123
Common Stock [Member]
Common stock issued upon dividends payable, shares			183,700
Shares issued, price per share		$ 4.95		$ 5.55																$ 5.25
Common stock issued under 401(k) profit sharing plan, shares																			9,509	12,079
Common stock issued under 401(k) profit sharing plan, value																			$ 95	$ 121
Number of shares common stock sold, shares																				878,257
Aggregate proceeds from sale of stock																				$ 4,610,700
Common stock issued for cash, shares				9,509																878,257
Number of shares issued for consulting service, shares		8,334																	76,027
Number of shares issued for consulting service		$ 31,350																	$ 760
Accounts payable		$ 12,000
Common stock issued for cash, value																				$ 8,783
Common Stock [Member] | Kingswood Capital Markets [Member]
Common stock issued for cash, shares	67,693
Common stock issued for cash, value	$ 335,080
Share-based payment award, vesting description	Of the shares issued, 20% of the shares were vested immediately (accordingly, $67,016 was recorded as deferred offering cost) and 80% vest upon the successful closing of a qualified offering within 180 days of the execution of the agreement (no accounting recognition through December 31, 2020, however, the shares vested on February 16, 2021 the shares when the Offering was completed).
Deferred offering cost	$ 67,016
Warrants [Member]
Number of cancelled warrants purchase shares										24,309
Convertible Notes [Member]
Shares converted into stock					395,136
Accredited Investors [Member]
Number of shares common stock sold, shares																			301,441
Aggregate proceeds from sale of stock																			$ 1,571,800
President and CEO [Member] | Warrants [Member]
Warrant to purchase of common stock shares										10,094
Minimum [Member]
Share-based payment award, fair value assumptions, expected term																			3 years 7 months 6 days	3 years 7 months 6 days
Share-based payment award, fair value assumptions, expected volatility rate																				51.00%
Minimum [Member] | Warrants [Member]
Warrant exercise price per share										$ 30.00
Maximum [Member]
Share-based payment award, fair value assumptions, expected term																			5 years	5 years
Share-based payment award, fair value assumptions, expected volatility rate																				52.00%
Maximum [Member] | Warrants [Member]
Warrant exercise price per share										$ 37.50
2018 Equity Incentive Plan [Member]
Share-based compensation arrangement by share-based payment award, number of shares available for grant											396,463								75,027					100,000
Increased percentage of common stock shares outstanding											2.50%													2.50%
Common stock exercisable price percentage																					110.00%
Number of stock options granted during the period														90,006
Option exercise price per share						$ 9.08								$ 5.78	$ 5.78
Option term														5 years		5 years
Percentage of option vested															25.00%	25.00%
Aggregate grant date fair value															$ 200,092	$ 56,797
2018 Equity Incentive Plan [Member] | Common Stock [Member]
Number of stock options granted during the period						102,346								73,336
Option term						5 years
Percentage of option vested						25.00%
Aggregate grant date fair value						$ 263,642
2018 Equity Incentive Plan [Member] | Common Stock [Member] | Certain Members of Board of Directors [Member]
Number of stock options granted during the period						20,001									6,668
2018 Equity Incentive Plan [Member] | Common Stock [Member] | Consultants [Member]
Number of stock options granted during the period						6,667									10,002	13,335
2018 Equity Incentive Plan [Member] | Employees [Member] | Common Stock [Member]
Number of stock options granted during the period						75,678
2018 Equity Incentive Plan [Member] | Minimum [Member]
Option exercise price per share																$ 8.85
2018 Equity Incentive Plan [Member] | Maximum [Member]
Option exercise price per share																$ 9.00
2018 Equity Incentive Plan [Member] | Beneficiary Ownership [Member] | Minimum [Member]
Minority interest percentage																					10.00%
2018 Gaucho Plan [Member]
Share-based compensation arrangement by share-based payment award, number of shares available for grant									100,000										2,280,000
2018 Gaucho Plan [Member] | Maximum [Member]
Share-based compensation arrangement by share-based payment award, number of shares available for grant																							8,000,000
401(k) Profit Sharing Plan [Member] | Common Stock [Member]
Shares issued, price per share													$ 5.25
Common stock issued under 401(k) profit sharing plan, shares													12,079
2008 Equity Incentive Plan [Member]
Number of stock options granted during the period												209,330
2008 Equity Incentive Plan [Member] | President and CEO [Member]
Number of stock options granted during the period												140,660
2008 Equity Incentive Plan [Member] | Chief Financial Officer [Member]
Number of stock options granted during the period												10,000
2008 Equity Incentive Plan [Member] | Board of Directors [Member]
Number of stock options granted during the period												10,000
2008 Equity Incentive Plan [Member] | Minimum [Member]
Option exercise price per share												$ 33.00
2008 Equity Incentive Plan [Member] | Maximum [Member]
Option exercise price per share												$ 37.20
2018 Stock Options Plan [Member] | Employees and Consultants [Member]
Number of stock options granted during the period											209,328
Option exercise price per share											$ 5.78
Percentage of option vested											25.00%
Aggregate grant date fair value											$ 398,199
2018 Stock Options Plan [Member] | President and CEO [Member] | Employees and Consultants [Member]
Number of stock options granted during the period											147,326
2018 Stock Options Plan [Member] | Chief Financial Officer [Member] | Employees and Consultants [Member]
Number of stock options granted during the period											10,334
2018 Stock Options Plan [Member] | Board of Directors [Member] | Employees and Consultants [Member]
Number of stock options granted during the period											10,000
2019 GGI Options [Member] | Advisor [Member]
Number of stock options granted during the period									100,000
Option exercise price per share									$ 0.55
Percentage of option vested									25.00%
Aggregate grant date fair value									$ 6,280
Share-based payment award, fair value assumptions, risk free interest rate									1.81%
Share-based payment award, fair value assumptions, expected term									3 years 9 months
Share-based payment award, fair value assumptions, expected volatility rate									32.00%
Share-based payment award, fair value assumptions, expected dividend rate									0.00%
2018 GGI Options [Member]
Number of stock options granted during the period																			5,720,000
Series A Convertible Preferred Stock [Member]
Preferred stock, shares authorized																			10,097,330	10,097,330
Preferred stock, par or stated value per share																			$ 0.01	$ 0.01
Series B Convertible Preferred Stock [Member]
Preferred stock, shares authorized																			901,070	902,670					902,670
Preferred stock, par or stated value per share																									$ 0.01
Preferred stock, shares outstanding																			901,070	902,670
Series B Preferred Stock [Member]
Dividends earned																			$ 721,752	$ 721,057
Declared dividends																			$ 1,626,306
Common stock issued upon dividends payable, shares																			183,700
Shares issued, price per share																			$ 8.36
Dividends payable																			$ 82,772	85,945
Preferred stock, amount of cumulative unpaid and undeclared dividends in arrears																			$ 449,788	$ 1,264,361
Fair market value of common stock																			$ 10
Shares converted into stock																			10
Preferred stock voting, description																			Each share of Series B stock is entitled to the number of votes determined by dividing $10 by the fair market value of the Company's common stock on the date that the Series B shares were issued, up to a maximum of ten votes per share of Series B stock. Each Series B share is convertible at the option of the holder into 10 shares of the Company's common stock and is automatically converted into common stock upon the uplisting of the Company's common stock to a national securities exchange. Pursuant to the amendment approved by the Board of Directors on December 29, 2020 and by the holders of a majority of the Series B stock on March 30, 2020, if the Series B has not automatically converted to common stock upon the uplisting of the Company's common stock to a national exchange by June 30, 2021, the Company will redeem all then-outstanding Series B shares at a price equal to the liquidation value of $10 per share, plus all unpaid accrued and accumulated dividends. As a result of this redemption feature and the fact that the Series B shares contain a substantive conversion option, the Series B shares are classified as temporary equity. Any adjustment to the Company's common stock for purposes of a stock split will be applied after conversion of the Series B shares to common stock on a 1 for 10 basis. Subsequent to December 31, 2020, as a result of the listing of the Common Stock on Nasdaq, all outstanding shares of Series B were converted into shares of Common Stock on a 1 for 10 basis and then adjusted for the reverse stock split on a 15 for 1 basis.
Series B Preferred Stock [Member] | Shareholder [Member]
Number of shares repurchased								1,600
Payment of accrued dividends								$ 2,451
Cumulative cash dividends annual rate								8.00%
Liquidation value per share								$ 10